About Technology Issues FAQ

Links

Official Page

Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study

Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.